IMGIP22070 / CL-SBP-101-04 / DunneResearch Question:
Does the drug, SBP-101 effectively treat metastatic pancreatic cancer?
Basic Study Information
Purpose:Location: University of Rochester
The study is a randomized, double-blind, placebo-controlled, multicenter study of
standard treatment with nab-paclitaxel and gemcitabine with or without SBP-101 in
subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA),
including subjects who have received prior neoadjuvant or adjuvant treatment.
Study Reference #: STUDY00007707
Lead Researcher (Principal Investigator)
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search